Kuvan mechanism of action?

How does Kuvan work (mechanism of action)?

Kuvan’s active ingredient is sapropterin dihydrochloride. It works by increasing the amount of available tetrahydrobiopterin (BH4) in the body, which helps some cases of phenylketonuria (PKU) process phenylalanine more effectively through the phenylalanine hydroxylase pathway [1].

Why does raising BH4 help in PKU?

Sapropterin acts as a BH4 precursor/supplement. BH4 is a required cofactor for phenylalanine hydroxylase, the liver enzyme that converts phenylalanine into tyrosine. By boosting BH4 availability, Kuvan can enhance this conversion and lower blood phenylalanine levels in patients whose PKU is BH4-responsive [1].

Who is most likely to respond to Kuvan?

Kuvan is intended for people with BH4-responsive PKU (a subset of PKU patients). In those patients, providing BH4 support can increase phenylalanine breakdown via the enzyme pathway. Patients without BH4 responsiveness typically do not get the same phenylalanine-lowering effect [1].

What are the key takeaways patients usually look for?

Kuvan does not work by directly removing phenylalanine. It improves the body’s ability to metabolize phenylalanine by supplying/raising BH4, a necessary cofactor for phenylalanine hydroxylase [1].

Does Kuvan change the enzyme itself?

Kuvan supports the existing metabolic pathway by providing BH4-related function rather than replacing or “fixing” the underlying genetic defect. The response depends on whether the phenylalanine hydroxylase pathway can be sufficiently activated by added BH4 [1].

Sources

1. Kuvan (sapropterin dihydrochloride) prescribing information – U.S. FDA